GC Aesthetics raises $60M to Fund Global Growth and New Product Development

February 21, 2014

DUBLIN, February 21, 2014 /PRNewswire/ –

GC Aesthetics (http://www.gcaesthetics.com), one of the largest independent
aesthetic companies globally, has raised $40M of financing from new investor OrbiMed,
alongside nearly $20M from existing investors including Montreux Equity Partners and
Oyster Capital. This financing will fuel further international expansion, new product
development and launches. It will continue to support GC Aesthetics’ vision to become the
world’s leading independent medical aesthetics company.

GC Aesthetics is a global leader in the aesthetic and plastic surgery market with
their flagship brands: UK-based Nagor and France-based Eurosilicone. GC Aesthetics has had
manufacturing plants in Europe for over 30 years, and plans further expansion of its
operations in Europe to meet the growing demand. The company, whose products sell in over
90 countries, has been growing their business worldwide with a new executive team at the
helm since the beginning of 2013.

Ayse Kocak, CEO of GC Aesthetics and the industry’s first-ever female CEO says: “We
are delighted to have secured this funding that will allow GC Aesthetics consolidate its
position as a market leader in aesthetics, and one which continues to keep women’s
interests at the forefront of all our goals. This has been an exciting year for us and we
have laid the foundations to launch groundbreaking initiatives. This funding will enable
us to maximise further growth, introduce our quality products to new markets and give
patients and surgeons more choice than ever before”.

Daniel K. Turner III, Managing Director of Montreux Equity Partners and Chairman of GC
Aesthetics, added, “Ayse and the GC Aesthetics management team are transforming the
aesthetics market with their focus on the health and wellness of women. Our continued
financial commitment demonstrates our excitement for GC Aesthetics growth prospects as it
becomes a global market leader in aesthetics.”


About GC Aesthetics

GC Aesthetics, which stands for Global Consolidated Aesthetics, was founded in 2007
and is the umbrella company for two leading implant manufacturers: Nagor and Eurosilicone.
The Dublin-based privately owned company has more than 60 years of combined experience and
excellence in implant development, manufacture and innovation and currently manufactures
and sells breast implants in 90 countries, offering a wide product range with nearly 600
types of implant. The company manufactures its products at its own facilities based in
Scotland, England and France and produces to the highest European standards. GC Aesthetics
is committed to the continuous improvement and evolution of the Eurosilicone
[http://www.eurosilicone.com ] and Nagor [http://www.nagor.com ] product lines and to
educating consumers by providing clear information on implants.

To contact GC Aesthetics, please email info@gcaesthetics.com and to visit the GC
Aesthetics website please go to http://www.gcaesthetics.com

About OrbiMed

OrbiMed (http://www.orbimed.com) is a leading investment firm dedicated
exclusively to the healthcare sector, with over $9 billion in assets under management.
OrbiMed invests globally across the spectrum of healthcare companies, from venture capital
start-ups to large multinational companies. OrbiMed’s team of more than 80 employees
manages a series of private equity funds, public equity funds, royalty/debt funds and
other investment vehicles. OrbiMed maintains its headquarters in New York City, with
additional offices in San Francisco, Shanghai, Mumbai and Herzliya.

About Montreux Equity Partners

Montreux is dedicated to making growth capital investments in category leading
companies with products, technologies, and services that are advancing health. Since 1993,
Montreux has invested in more than 50 companies, including MAKO Surgical (acquired by
Stryker), SkinMedica (acquired by Allergan), Renal CarePartners (acquired by Ambulatory
Services of America), Great Lakes Health Plan (acquired by United Healthcare), and
Orexigen (Nasdaq: OREX). Montreux is based in San Francisco, CA and is currently investing
out of its fifth fund. For more information, visit mepvc.com [http://www.mepvc.com ].

About Oyster Capital

Oyster was founded in 2000 by Bill McCabe, one of Ireland’s most successful
entrepreneurs, and the firm invests in technology, software, waste and energy businesses.
Since its inception, it has invested in more than 30 companies and has offices both in
Ireland and USA.

Contact: info@gcaesthetics.com

SOURCE GC Aesthetics

Source: PR Newswire

comments powered by Disqus